Transitional cell neoplasms of the ovary and urinary bladder: A comparative immunohistochemical analysis

International Journal of Gynecological Pathology

Volumn 15, Issue 3, 1996, Pages 257-265

  Soslow, Robert A ^c   Rouse, Robert V ^a,b   Hendrickson, Michael R ^a   Silva, Elvio G ^d   Longacre, Teri A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^c WEILL CORNELL MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS   (United States)

Author keywords

Brenner tumor; Cytokeratin; Immunohistology; Ovary; Transitional cell carcinoma; Transitional cell proliferations

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN; MONOCLONAL ANTIBODY;

ARTICLE; BLADDER CARCINOMA; BRENNER TUMOR; CLINICAL ARTICLE; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; IMMUNOPHENOTYPING; OVARY CARCINOMA; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; TUMOR DIAGNOSIS;

EID: 0029948124     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004347-199607000-00011     Document Type: Article

References (43)

1. Scully RE. Recent progress in ovarian cancer. Hum Pathol 1970;1:73-98.
2. Shevchuk MM, Fenoglio CM, Richart RM. Histogenesis of Brenner tumors. I. Histology and ultrastructure. Cancer 1980;46:2607-16.
3. Shevchuk MM, Fenoglio CM, Richart RM. Histogenesis of Brenner tumors. II. Histochemistry and CEA. Cancer 1980; 46:2617-22.
4. Roth L. The Brenner tumor and the Walthard cell nest: an electron microscopic study. Lab Invest 1974;31:15-23.
5. Roth L, Dallenbach-Hellweg G, Czernobilsky B. Ovarian Brenner tumors. I. Metaplastic, proliferating and of low malignant potential. Cancer 1985;56:582-91.
6. Merkow LP, Salazar H, Pardo M. Human ovarian neoplasms, light and electron microscopic correlations. I. The Brenner tumor. Obstet Gynecol 1972;40:667-80.
7. Bransilver BR, Ferenczy A, Richart RM. Brenner tumors and Walthard cell nests. Arch Pathol 1974;98:76-85.
8. Santini D, Gelli MC, Mazzoleni G, et al. Brenner tumor of the ovary: correlative histologic, histochemical, immunohistochemical, and ultrastructural investigation. Hum Pathol 1989;20:787-95.
9. Fulker M, Cooper E, Tanaka T. Proliferation and ultrastructure of papillary transitional cell carcinoma of the human bladder. Cancer 1971;27:71-82.
10. Cummins P, Fox H, Langley F. An ultrastructural study of the nature and origin of the Brenner tumor of the ovary. J Pathol 1973;110:167-76.
11. Fetissof F, Dubois M, Arbeille-Brassart B, Lanson Y, Boivin F, Jobard P. Endocrine cells in the prostate gland, urothelium and Brenner tumors. Immunohistochemical and ultrastructural studies. Virchows Arch [B] 1983;42:53-64.
12. Aguirre P, Scully R, Wolfe H, DeLeliis R. Argyrophil cells in Brenner tumors: histochemical and immunohistochemical analysis. Int J Gynecol Pathol 1986;5:223-34.
13. Ganjei P, Nadji M, Penneys N, Averette H, Morales A. Immunoreactive prekeratin in Brenner tumors of the ovary. Int J Gynecol Pathol 1983;1:353-8.
14. Miettinen M, Keratin 20: immunohistochemical marker for gastrointestinal, urothelial, and Merkel cell carcinomas. Mod Pathol 1995;8:384-8.
15. Purnell DM, Heatfield BM, Trump BF. Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate specific antigen. Cancer Res 1984;44:285-90.
16. Sheahan K, O'Brien MJ, Burke B, et al. Differential reactivities of carcinoembryonic antigen (CEA) and CEA-related monoclonal and polyclonal antibodies in common epithelial malignancies. Am J Clin Pathol 1990;94:157-64.
17. Loy TS, Sharp SC, Andershock CJ, Craig SB. Distribution of CA19-9 in adenocarcinomas and transitional cell carcinomas. Am J Clin Pathol 1993;99:726-8.
18. Gatalica Z, Miettinen M. Distribution of carcinoma antigens CA19-9 and CA15-3. Appl Immunohistochem 1994;2:205-11.
19. Ramaekers F, Huysmans A, Schaart G, Moesker O, Vooijs P. Tissue distribution of keratin 7 as monitored by a monoclonal antibody. Exp Cell Res 1987;170:235-49.
20. Ramaekers F, Niekerk CV, Poels L, et al. Use of monoclonal antibodies to keratin 7 in the differential diagnosis of adenocarcinomas. Am J Pathol 1990;136:641-55.
21. Moll R, Achtstätter T, Becht E, Balcarova-Ständer J, Ittensohn M, Franke WW. Cytokeratins in normal and malignant transitional epithelium. Maintenance of expression of urothelial differentiation features in transitional cell carcinomas and bladder carcinoma cell culture lines. Am J Pathol 1988;132:123-44.
22. Moll R, Löwe A, Laufer J, Franke WW. Cytokeratin 20 in human carcinomas. A histodiagnostic marker detected by monoclonal antibodies. Am J Pathol 1992;140:427-47.
23. Austin R, Norris H. Malignant Brenner tumor and transitional cell carcinoma of the ovary: a comparison. Int J Gynecol Pathol 1987;6:29-39.
24. Miles P, Norris H. Proliferative and malignant Brenner tumors of the ovary. Cancer 1972;30:174-86.
25. Robey S, Silva E, Gershenson D, McLemore D, El-Nagger A, Ordonez N. Transitional cell carcinoma in high-grade high-stage ovarian carcinoma. An indicator of favorable response to chemotherapy. Cancer 1989;63:839-49.
26. Roth L, Czernobilsky B. Ovarian Brenner tumors. II. Malignant. Cancer 1985;56:592-601.
27. Roth L, Gersell D, Ulbright T, Ovarian Brenner tumors and transitional cell carcinoma: recent developments. Int J Gynecol Pathol 1993;12:128-33.
28. Longacre TA, Smoller BR, Rouse RV: Atypical fibroxanthoma: multiple immunohistologic profiles. Am J Surg Pathol 1993;17:1199-209.
29. Wick M. Monoclonal antibodies to carcinoembryonic anti gen in diagnostic immunohistochemistry. In: Wick MR, Siegal GP, eds. Monoclonal antibodies in diagnostic immunohistochemistry. New York: Marcel Dekker, 1988:539-67.
30. Charpin C, Bhan AK, Zurawski VR, Scully RE. Carcinoembryonic antigen (CEA) and carbohydrate determinant 19-9 (CA19-9) localization in 121 primary and metastatic ovarian tumors: an immunohistochemical study with the use of monoclonal antibodies. Int J Gynecol Pathol 1982;1:231-45.
31. Breitenecker G, Neunteufel W, Bieglmayer C, Kolbl H, Schieder K. Comparison between tissue and serum content of CA125, CA19-9, and carcinoembryonic antigen in ovarian tumors. Int J Gynecol Pathol 1989;8:97-102.
32. Helle M, Helin H, Ashorn P, Putkinen EL, Krohn K, Wahlström T. The expression of CEA, CA19-9 and HMFG antigens in ovarian clear cell and endometrioid carcinomas. Path Res Pract 1992;188:74-7.
33. Nouwen EJ, Hendrix PG, Dauwe S, Eerdekens MW, de Broe ME. Tumor markers in the human ovary and its neoplasms. A comparative immunohistochemical study. Am J Pathol 1987;126:230-42.
34. Wauters CAP, Smedts F, Gerrits LGM, Bosman FT, Ramaekers FCS. Keratins 7 and 20 as diagnostic of carcinomas metastatic to the ovary. Hum Pathol 1995;26:852-5.
35. Ueda G, Sawada M, Ogawa H, Tanizawa O, Tsujimoto M. Immunohistochemical study of cytokeratin 7 for the differential diagnosis of adenocarcinomas in the ovary. Gynecol Oncol 1993;51:219-23.
36. Moll R, Schiller DL, Franke WW. Identification of protein IT of the intestinal cytoskeleton as a novel type I cytokeratin with unusual properties and expression patterns. J Cell Biol 1990;111:567-80.
37. Moll R, Zimbelmann R, Goldschmidt MD, et al. The human gene encoding cytokeratin 20 and its expression during fetal development and in gastrointestinal carcinomas. Differentiation 1993;53:75-93.
38. Robboy S, Scully R, Norris H. Carcinoid metastatic to the ovary. A clinicopathologic analysis of 20 cases. Cancer 1974;33:798-811.
39. Hsiu JG, Kemp GM, Singer GA, Rawls WH, Siddiky MA. Transitional cell carcinoma of the renal pelvis with ovarian metastasis. Gynecol Oncol 1991;41:178-81.
40. Young R, Scully R. Urothelial and ovarian carcinomas of identical cell types: problems in interpretation. A report of three cases and review of the literature. Int J Gynecol Pathol 1988;7:197-211.
41. van der Weiden R, Gratama S. Proliferative and malignant Brenner tumors (BT) and their differentiation from metastatic transitional cell carcinoma of the bladder: a case report and review of the literature. Eur J Obstet Gynecol Reprod Biol 1987;26:251-60.
42. Young R, Gersell D, Roth L, Scully R. Ovarian metastases from cervical carcinomas other than pure adenocarcinomas. Cancer 1993;71:407-18.
43. Suva E, Robey-Cafferty S, Smith T, Gershenson D. Ovarian carcinomas with transitional cell carcinoma pattern. Am J Clin Pathol 1990;93:457-65.